Status:
COMPLETED
Next-Generation Pre-Operative Targeting for Thalamic DBS in the Treatment of Tremor
Lead Sponsor:
Mayo Clinic
Conditions:
Essential Tremor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Researchers are investigating improved methods of targeting deep brain stimulators for treatment of essential tremor relying on brain connectivity measures derived from MRI.
Eligibility Criteria
Inclusion
- Diagnosis of refractory essential tremor scheduled for unilateral thalamic deep brain stimulator placement
- Age ≥ 18 years
Exclusion
- Prior deep brain stimulator, stereotactic radiosurgery, or focused ultrasound procedure for treatment of tremor
- Presence of concomitant movement disorder (e.g. Parkinson's disease, dystonia, etc.)
- Known pre-existing structural brain abnormality (e.g, infarction, tumor, prior brain surgery, etc.)
- Contraindication to 3 Tesla brain MRI (e.g. incompatible implanted device)
- Pregnant
Key Trial Info
Start Date :
March 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2021
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03875404
Start Date
March 20 2019
End Date
February 12 2021
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224